Wells Fargo analyst Stephen Baxter downgraded Tenet Healthcare (THC) to Equal Weight from Overweight with a price target of $150, down from $205. The firm cut out-year estimates for the hospitals to reflect its assumption that enhanced exchange subsidies will expire. Current policy and fiscal uncertainty warrant lower multiples in the group, the analyst tells investors in a research note. Wells sees the extension of enhanced exchange subsidies as unlikely following the Republican sweep. Assuming the expiration of enhanced subsidies was a 50% probability before the election and a 100% probability now, the group multiples are little changed since the election, contends Wells. It expects “uncertainty to remain high for some time.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THC:
- Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz
- Tenet Healthcare downgraded to Outperform from Strong Buy at Raymond James
- Commure to deploy Commure Scribe on Tenet Physician Resources
- Tenet Healthcare management to meet with Truist
- Tenet Healthcare price target raised to $190 from $171 at Barclays